Literature DB >> 26328934

Three new milbemycins from a genetically engineered strain S. avermitilis MHJ1011.

Jun-jie Pan1, Xu Wan1, Hui Zhang2, Zhen Chen1, Jun Huang2, Bo Yang1, An-liang Chen1, Ji-dong Wang1,2.   

Abstract

Three new β-class milbemycins, 13α-hydroxy-4-ethy1 milbemycin β3 (1), 13α-hydroxy-25-ethy1 milbemycin β3 (2), 13α-hydroxy milbemycin β3 (3), were isolated from the broth of the genetically engineered strains Streptomyces avermitilis MHJ1011, whose aveA1 gene was replaced by milA1 gene seamlessly. Their structures were determined on the basis of extensive spectroscopic analysis and comparison with data from the literature. These three compounds, especially compound 1, exhibited potent acaricidal activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26328934     DOI: 10.1038/ja.2015.90

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

1.  Engineering a polyketide with a longer chain by insertion of an extra module into the erythromycin-producing polyketide synthase.

Authors:  C J Rowe; I U Böhm; I P Thomas; B Wilkinson; B A Rudd; G Foster; A P Blackaby; P J Sidebottom; Y Roddis; A D Buss; J Staunton; P F Leadlay
Journal:  Chem Biol       Date:  2001-05

2.  Synthesis and biological activity of 13-epi-avermectins: potent anthelmintic agents with an increased margin of safety.

Authors:  T A Blizzard; G M Margiatto; H Mrozik; W L Shoop; R A Frankshun; M H Fisher
Journal:  J Med Chem       Date:  1992-10-16       Impact factor: 7.446

3.  Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products.

Authors:  R McDaniel; A Thamchaipenet; C Gustafsson; H Fu; M Betlach; G Ashley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 4.  Combinatorial biosynthesis of polyketides--a perspective.

Authors:  Fong T Wong; Chaitan Khosla
Journal:  Curr Opin Chem Biol       Date:  2012-02-16       Impact factor: 8.822

5.  A labile point in mutant amphotericin polyketide synthases.

Authors:  Naseem Khan; Bernard Rawlings; Patrick Caffrey
Journal:  Biotechnol Lett       Date:  2011-01-26       Impact factor: 2.461

6.  Gene Replacement for the Generation of Designed Novel Avermectin Derivatives with Enhanced Acaricidal and Nematicidal Activities.

Authors:  Jun Huang; An-Liang Chen; Hui Zhang; Zhen Yu; Mei-Hong Li; Na Li; Jia-Tan Lin; Hua Bai; Ji-Dong Wang; Yu-Guo Zheng
Journal:  Appl Environ Microbiol       Date:  2015-05-29       Impact factor: 4.792

7.  Analysis and manipulation of amphotericin biosynthetic genes by means of modified phage KC515 transduction techniques.

Authors:  Maria Carmody; Barry Byrne; Barry Murphy; Ciaran Breen; Susan Lynch; Elizabeth Flood; Shirley Finnan; Patrick Caffrey
Journal:  Gene       Date:  2004-12-08       Impact factor: 3.688

8.  Milbemycins, a new family of macrolide antibiotics: fermentation, isolation and physico-chemical properties.

Authors:  Y Takiguchi; H Mishima; M Okuda; M Terao; A Aoki; R Fukuda
Journal:  J Antibiot (Tokyo)       Date:  1980-10       Impact factor: 2.649

Review 9.  Macrocyclization strategies in polyketide and nonribosomal peptide biosynthesis.

Authors:  Florian Kopp; Mohamed A Marahiel
Journal:  Nat Prod Rep       Date:  2007-05-10       Impact factor: 13.423

10.  Two new beta-class milbemycins from streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties.

Authors:  Wen-Sheng Xiang; Ji-Dong Wang; Xiang-Jing Wang; Ji Zhang
Journal:  J Antibiot (Tokyo)       Date:  2007-06       Impact factor: 2.649

View more
  4 in total

1.  Isolation and identification of new macrocyclic lactones from a genetically engineered strain Streptomyces bingchenggensis BCJ60.

Authors:  Jiansong Li; Shaoyong Zhang; Hui Zhang; Haiyan Wang; Ji Zhang; Anliang Chen; Jidong Wang; Wensheng Xiang
Journal:  J Antibiot (Tokyo)       Date:  2016-10-26       Impact factor: 2.649

2.  New tenvermectin analogs obtained by microbial conversion with Saccharopolyspora erythraea.

Authors:  Xu Wan; Shao-Yong Zhang; Hui Zhang; Jun Zhai; Jun Huang; An-Liang Chen; Ji-Dong Wang
Journal:  J Antibiot (Tokyo)       Date:  2016-07-20       Impact factor: 2.649

3.  In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei.

Authors:  Kate E Mounsey; Shelley F Walton; Ashlee Innes; Skye Cash-Deans; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 4.  Natural Products Research in China From 2015 to 2016.

Authors:  Haishan Liu; Guoliang Zhu; Yaqin Fan; Yuqi Du; Mengmeng Lan; Yibo Xu; Weiming Zhu
Journal:  Front Chem       Date:  2018-03-20       Impact factor: 5.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.